past
decad
advanc
new
molecular
techniqu
led
detect
variou
potenti
respiratori
virus
human
metapneumoviru
hmpv
van
den
hoogen
et
al
human
coronaviru
hcov
van
der
hoek
et
al
woo
et
al
sever
acut
respiratori
syndromecoronaviru
sarscov
drosten
et
al
human
bocaviru
hbov
alland
et
al
hbov
first
isol
nasopharyng
specimen
children
respiratori
tract
infect
alland
et
al
hbov
small
nonenvelop
viru
approxim
kb
singlestrand
dna
genom
classifi
famili
parvovirida
subfamili
parvovirina
genu
bocaviru
sinc
first
identifi
hbov
detect
worldwid
respiratori
sampl
sever
studi
shown
hbov
associ
acut
respiratori
tract
infect
young
children
report
worldwid
preval
rang
bastien
et
al
alland
et
al
fri
et
al
recent
year
three
close
relat
variant
hbov
report
design
arthur
et
al
kapoor
et
al
discov
stool
children
nonpolio
acut
flaccid
paralysi
pakistan
soon
thereaft
identifi
stool
children
diarrhoea
australia
usa
arthur
et
al
kapoor
et
al
date
link
frequent
respiratori
tract
ill
particularli
children
bastien
et
al
kesebir
et
al
alland
et
al
fri
et
al
maggi
et
al
although
also
detect
stool
sampl
lesser
extent
albuquerqu
et
al
lau
et
al
lee
et
al
contrast
occur
rare
respiratori
sampl
instead
found
primarili
stool
children
indic
associ
gastrointestin
diseas
arthur
et
al
chieochansin
et
al
han
et
al
kapoor
et
al
chow
et
al
santo
et
al
interestingli
identif
recent
epidemiolog
clinic
characterist
associ
virus
realiz
arthur
et
al
chieochansin
et
al
kapoor
et
al
santo
et
al
clinic
signific
molecular
characterist
newli
identifi
hbov
speci
complet
assess
aim
studi
determin
epidemiolog
clinic
profil
hbov
infect
investig
presenc
analys
hbov
molecular
phylogeni
nasopharyng
aspir
children
acut
respiratori
tract
infect
januari
decemb
nasopharyng
specimen
collect
children
hospit
acut
respiratori
tract
infect
sever
children
hospit
seoul
korea
part
diagnosi
pneumonia
croup
bronchiol
asthma
acut
pharyngotonsil
acut
nasopharyng
acut
respiratori
distress
syndrom
ard
includ
diagnos
physician
physic
examin
chest
xray
accord
world
health
organ
recommend
guidelin
world
health
organ
patient
immunocompromis
condit
eg
current
treatment
chemotherapi
immunosuppress
therapi
bone
marrow
transplant
known
primari
immun
defici
exclud
studi
nasopharyng
aspir
obtain
suction
use
fine
flexibl
plastic
cathet
syring
immedi
transport
laboratori
store
use
review
medic
record
interview
admiss
patient
demograph
clinic
data
includ
medic
histori
detail
sign
symptom
physic
examin
laboratori
radiolog
result
collect
diseas
sever
assess
accord
respiratori
symptom
score
system
base
previous
publish
metric
gern
et
al
lemansk
et
al
viral
dna
rna
nasopharyng
sampl
extract
qiaamp
viral
mini
kit
qiagen
hilden
germani
accord
manufactur
protocol
onestep
multiplex
pcrrtpcr
kit
solgent
daejeon
korea
use
detect
respiratori
virus
chun
et
al
includ
hbov
respiratori
syncyti
viru
rsv
human
rhinoviru
hrv
influenza
viru
iav
influenza
b
viru
ibv
hmpv
adenoviru
adv
hcov
parainfluenza
virus
piv
amplif
perform
accord
manufactur
instruct
product
run
agaros
gel
stain
ethidium
bromid
visual
uv
light
hbovposit
specimen
amplifi
nest
pcr
use
panbocaviru
pcr
primer
target
gene
describ
previous
kapoor
et
al
posit
pcr
sampl
sequenc
solgent
co
daejeon
korea
sequenc
align
clustral
w
phylogenet
analysi
conduct
mega
softwar
topolog
tree
drawn
neighbourjoin
method
kimura
model
bootstrap
replic
statist
analysi
perform
spss
version
chicago
il
valu
express
percentag
discret
variabl
mean
ae
standard
deviat
sd
continu
variabl
clinic
featur
laboratori
variabl
analyz
use
pearson
x
test
fisher
exact
test
student
ttest
pvalu
less
consid
statist
signific
hbov
detect
nasopharyng
aspir
overal
hbov
fourth
frequent
pathogen
identifi
studi
patient
follow
hrv
adv
rsv
fig
total
hbovposit
sampl
codetect
respiratori
virus
one
addit
viru
found
two
three
hrv
adv
hmpv
frequent
codetect
tabl
season
distribut
hbov
note
march
decemb
peak
occur
month
june
fig
hbovposit
patient
male
femal
signific
differ
hbov
posit
neg
patient
tabl
ii
mean
ae
sd
age
hbov
infect
children
ae
month
significantli
less
hbovneg
group
ae
month
tabl
ii
group
age
month
highest
rate
hbov
infect
group
month
age
lowest
rate
fig
case
hbov
infect
main
diagnosi
pneumonia
follow
bronchiol
croup
asthma
acut
pharyngotonsil
acut
nasopharyng
ard
previou
wheez
histori
p
frequenc
chest
retract
wheez
p
p
respect
respiratori
symptom
score
p
length
hospit
stay
p
significantli
higher
hbovposit
group
hbovneg
children
tabl
ii
alanin
aminotransferas
alt
aspart
aminotransferas
ast
group
within
normal
rang
although
signific
differ
p
p
respect
tabl
ii
asid
alt
ast
signific
differ
observ
respect
underli
histori
prematur
congenit
heart
diseas
neurolog
disord
frequenc
tachypnea
laboratori
find
hbov
posit
neg
patient
tabl
ii
children
hbov
specimen
detect
coinfect
hbov
virus
signific
differ
clinic
laboratori
data
gender
ratio
p
percentag
neutrophil
white
blood
cell
wbc
p
total
protein
p
tabl
iii
howev
neutrophil
ratio
wbc
total
protein
within
normal
rang
group
investig
diverg
hbov
genom
fragment
gene
nucleotid
sequenc
hbovposit
sampl
phylogenet
analysi
demonstr
hbovposit
strain
hbov
hbov
detect
fig
high
nucleotid
ident
hbov
sequenc
nucleotid
variat
conserv
amino
acid
level
sequenc
ident
among
strain
overal
compar
swedish
refer
strain
access
number
nucleotid
posit
found
variabl
transit
transvers
signific
differ
observ
clinic
laboratori
data
group
nucleotid
variat
wildtyp
sinc
first
report
hbov
detect
frequent
worldwid
respiratori
sampl
report
preval
rang
schildgen
et
al
tran
et
al
korea
sever
report
presenc
hbov
publish
frequenc
rang
choi
et
al
choi
et
al
choi
et
al
chung
et
al
kim
et
al
present
studi
hbov
detect
respiratori
sampl
differ
frequenc
present
studi
previous
report
may
relat
differ
studi
popul
period
nevertheless
studi
confirm
hbov
circul
frequent
korean
children
acut
respiratori
tract
infect
fourth
preval
viru
among
respiratori
virus
test
previou
studi
report
season
prefer
hbov
infect
vari
among
differ
counti
schildgen
et
al
differ
thought
due
differ
climat
variou
factor
affect
preval
respiratori
infect
countri
studi
peak
hbov
infect
occur
month
june
result
similar
two
earlier
studi
choi
et
al
kim
et
al
korea
report
hbov
infect
peak
may
june
april
june
close
accord
previou
studi
studi
suggest
hbov
especi
preval
late
spring
earli
summer
season
korea
age
distribut
data
studi
show
mean
ae
sd
age
significantli
younger
hbovposit
patient
compar
hbovneg
patient
peak
incid
hbov
observ
children
age
month
lowest
incid
children
older
month
result
close
agreement
numer
previou
studi
kesebir
et
al
fri
et
al
maggi
et
al
show
patient
hbov
infect
infant
children
year
age
previou
seroepidemiolog
studi
hbov
show
seroposit
rate
children
age
month
drop
children
month
old
like
due
wane
level
maternallyacquir
antibodi
endo
et
al
percentag
hbovseroposit
patient
rebound
increas
age
children
expos
hbov
age
six
one
studi
kahn
et
al
show
although
infant
month
old
hbovseroposit
seroposit
rate
lowest
children
age
month
increas
children
month
old
togeth
data
suggest
infant
younger
month
age
may
protect
hbov
infect
matern
antibodi
first
hbov
infect
begin
loss
matern
antibodi
major
hbov
infect
occur
earli
childhood
addit
lower
rate
detect
hbov
older
children
adult
report
sever
studi
alland
et
al
alland
et
al
fri
et
al
lau
et
al
han
et
al
noh
et
al
may
due
lifelong
immun
acquir
infect
earli
childhood
respect
clinic
featur
hbov
infect
present
studi
show
hbovposit
children
higher
preval
prior
wheez
histori
higher
frequenc
chest
retract
wheez
higher
respiratori
symptom
score
longer
durat
hospit
stay
compar
hbovneg
group
result
agreement
previou
studi
report
associ
hbov
acut
wheez
children
choi
et
al
chung
et
al
alland
et
al
fri
et
al
deng
et
al
well
respiratori
distress
hypoxia
main
clinic
characterist
hbov
infect
moriyama
et
al
addit
sever
studi
shown
hbov
caus
sever
exacerb
asthma
children
naghipour
et
al
vallet
et
al
although
impact
coinfect
virus
consid
result
studi
show
signific
differ
clinic
featur
children
hbov
infect
alon
coinfect
anoth
viru
impli
hbovposit
patient
experi
clinic
sever
respiratori
distress
wheez
longer
hospit
regardless
coinfect
statu
deng
et
al
suggest
high
hbov
viral
load
could
lead
longer
durat
wheez
hospit
children
sever
lower
respiratori
tract
infect
coinfect
influenc
clinic
sever
outcom
hbov
infect
present
studi
respiratori
sampl
detect
well
describ
associ
respiratori
ill
although
recent
report
describ
preval
respiratori
specimen
children
han
et
al
song
et
al
koseki
et
al
role
respiratori
diseas
remain
unclear
occur
rare
respiratori
sampl
fairi
common
stool
children
arthur
et
al
chieochansin
et
al
han
et
al
kapoor
et
al
kapoor
et
al
chow
et
al
santo
et
al
suggest
associ
gastrointestin
diseas
result
present
studi
indic
directli
involv
respiratori
tract
infect
presum
detect
rare
respiratori
secret
origin
gastrointestin
mucosa
due
contamin
oral
secret
time
sampl
although
fig
phylogenet
analysi
gene
junction
sequenc
hbov
isol
topolog
tree
construct
neighbourjoin
method
use
mega
black
dot
design
refer
strain
sequenc
analyz
present
studi
genbank
access
no
lwk
hbov
strain
hbov
strain
studi
need
determin
associ
clinic
ill
outsid
gastrointestin
tract
phylogenet
analysi
studi
confirm
result
previou
find
alland
et
al
chung
et
al
kesebir
et
al
lau
et
al
nesk
et
al
show
highli
conserv
low
degre
genet
variabl
base
result
lau
et
al
predict
hbov
infect
may
occur
subsequ
develop
lifelong
immun
confer
neutral
antibodi
addit
postul
respiratori
infect
might
homogen
pattern
clinic
epidemiolog
featur
low
genet
divers
support
possibl
studi
result
indic
signific
differ
respect
clinic
laboratori
data
children
without
minor
variat
specif
even
though
strain
nucleotid
variat
hbov
isol
identifi
strain
result
amino
acid
substitut
thu
strain
nucleotid
variat
thought
biolog
characterist
nonmut
hbov
addit
two
strain
amino
acid
substitut
exhibit
specif
clinic
featur
suggest
may
influenc
biolog
action
hbov
contrast
sever
novel
type
detect
studi
exhibit
high
degre
genet
divers
rel
arthur
et
al
kapoor
et
al
kapoor
et
al
find
suggest
differ
clinic
impact
support
propos
directli
involv
respiratori
diseas
studi
sever
limit
first
studi
patient
limit
children
hospit
respiratori
infect
singlecentr
second
quantif
viral
load
would
use
analyz
coinfect
case
clearli
measur
third
lack
asymptomat
control
group
fourth
evalu
caus
agent
acut
respiratori
infect
cover
respiratori
virus
bacteri
viral
pathogen
caus
acut
respiratori
ill
investig
despit
shortcom
data
aid
understand
role
hbov
play
respiratori
ill
summari
minim
sequenc
variat
circul
children
acut
respiratori
infect
associ
sever
clinic
characterist
includ
age
season
clinic
sever
retract
wheez
longer
hospit
conclud
import
respiratori
pathogen
young
children
exhibit
homogen
pattern
clinic
epidemiolog
featur
due
rel
minor
degre
genet
variat
studi
need
clarifi
clinic
relev
minim
sequenc
variat
within
defin
clinic
role
